Literature DB >> 31327489

Usefulness of Calculation of Cardiovascular Risk Factors to Predict Outcomes in Patients With Acute Myocardial Infarction.

Chang-Yeon Kim1, Jang Hoon Lee2, Se Yong Jang3, Myung Hwan Bae3, Dong Heon Yang3, Hun Sik Park3, Yongkeun Cho3, Myung Ho Jeong4, Jong-Seon Park5, Hyo-Soo Kim6, Seung-Ho Hur7, In-Whan Seong8, Myeong-Chan Cho9, Chong-Jin Kim10, Shung Chull Chae3.   

Abstract

Cardiovascular risk factors contribute differently to short-term prognosis of acute myocardial infarction (AMI); hypertension and diabetes increase adverse outcomes, whereas hyperlipidemia, smoking, and obesity seem to paradoxically decrease these in post-MI patients. We aimed to investigate whether a simple calculation of conventional risk factors, PARADOCS (Pressure of ARtery elevAtion, Diabetes, Obesity, Cholesterol, Smoking) score, would improve the ability to predict major adverse cardiac and cerebrovascular events (MACCEs) in post-MI patients. Between November 2011 and December 2015, 13,104 patients with diagnosis of AMI were analyzed in this study from Korean AMI Registry - National Institute of Health database. PARADOCS score was calculated as follows: (number of nonparadoxical risk factors - number of paradoxical risk factors) + 3 where nonparadoxical risk factors are hypertension and diabetes, and paradoxical risk factors are hyperlipidemia, smoking, and obesity. PARADOCS score was significantly greater in patients with 1-year MACCEs compared with those without MACCEs (3.43 ± 1.03 vs 2.88 ± 1.11, p <0.001). In Cox proportional hazards model, PARADOCS score was an independent predictor of 1-year MACCEs (hazards ratio 1.23, 95% confidence interval 1.16 to 1.30; p <0.001) after adjusting for confounding variables. In Kaplan-Meier survival curve, patients with greater PARADOCS score had worse clinical outcome. In conclusion, although it needs more validation, a simple calculation of risk factors, PARADOCS score, could provide useful prognostic information of MI patients to clinicians.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31327489     DOI: 10.1016/j.amjcard.2019.06.010

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Isofraxidin Alleviates Myocardial Infarction Through NLRP3 Inflammasome Inhibition.

Authors:  Guofan Chen; Xiaozheng Song; Dongming Lin; Peng Xu
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

Review 2.  Prognostic implications for patients after myocardial infarction: an integrative literature review and in-depth interviews with patients and experts.

Authors:  Seon Young Hwang; Sun Hwa Kim; In Ae Uhm; Jeong-Hun Shin; Young-Hyo Lim
Journal:  BMC Cardiovasc Disord       Date:  2022-08-02       Impact factor: 2.174

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.